Investor's Business Daily on MSN
Why small biotech stock Corvus Pharma just launched to an eight-year high
Biotech stock Corvus Pharmaceuticals catapulted to an eight-year high Tuesday on promising results in eczema treatment.
ORLANDO (Nov. 6, 2025) – New research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that the timing of when eczema begins, as well as ...
Rising misuse of unregulated creams and delays in treatment are driving more severe eczema cases in Malaysia, specialists ...
Experts review emerging contact allergens found in consumer products and medical implants, highlighting new diagnostic ...
Infants diagnosed with severe eczema or an egg allergy may be more likely to develop peanut allergy (PA), according to baseline results from the Learning Early About Peanut Allergy (LEAP) study. The ...
The intersection of eczema treatment and long-term health consequences has revealed an emerging crisis in skincare management. What begins as a standard treatment protocol often evolves into an ...
LEO Pharma A/S, a global leader in medical dermatology, today presented two late-breaking delgocitinib cream presentations for Chronic Hand Eczema (CHE), showcasing the findings for the DELTA TEEN ...
Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of eczema, known as atopic dermatitis, is characterized by persistent itching ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果